Braka Fiona
Biographic Data
| ID | 9020511 |
|---|---|
| NAME | Braka Fiona |
| GIVEN NAMES | Braka |
| FAMILY NAME | Fiona |
| SIGNATURE | FIONA B |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 0 |
Nigeria’s public health response to the Covid-19 pandemic
The novel coronavirus disease 2019, COVID-19, which is caused by severe acute respiratory syndrome \nvirus 2 (SARS-CoV-2) [1] was first reported in December 2019 by Chinese Health Authorities following an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province [2,3]. SARS-CoV-2 is \nlikely of zoonotic origin, similar to SARS and Middle East Respiratory Syndrome (MERS), and transmitted between humans through respiratory droplets and fomit…
Targeting the last polio sanctuaries with Directly Observed Oral Polio Vaccination (Dopv) in northern Nigeria, (2014–2016)
Directly observed polio vaccination strategy improved uptake of polio vaccines and population immunity in high-risk areas for polio transmission
Towards an effective poliovirus laboratory containment strategy in Nigeria
This article is amongst the first in Africa that relates poliovirus laboratory containment in the context of the tOPV-bOPV switch in alignment with the Global Action Plan III. All identified infectious materials were destroyed and personnel trained to continue to destroy subsequent materials, a process that needs meticulous monitoring to mitigate the risk of poliovirus re-introduction to the population
Profile of polio-compatible cases in Nigeria, 2006–2016
AFP surveillance performance has improved significantly during the reporting period. Surveillance gaps still existed as shown by the presence of orphan viruses and polio-compatible cases, and these gaps need to be identified and closed to achieve certification
No prominent works on this page.
Targeting the last polio sanctuaries with Directly Observed Oral Polio Vaccination (Dopv) in northern Nigeria, (2014–2016)
Directly observed polio vaccination strategy improved uptake of polio vaccines and population immunity in high-risk areas for polio transmission
Towards an effective poliovirus laboratory containment strategy in Nigeria
This article is amongst the first in Africa that relates poliovirus laboratory containment in the context of the tOPV-bOPV switch in alignment with the Global Action Plan III. All identified infectious materials were destroyed and personnel trained to continue to destroy subsequent materials, a process that needs meticulous monitoring to mitigate the risk of poliovirus re-introduction to the population
Profile of polio-compatible cases in Nigeria, 2006–2016
AFP surveillance performance has improved significantly during the reporting period. Surveillance gaps still existed as shown by the presence of orphan viruses and polio-compatible cases, and these gaps need to be identified and closed to achieve certification
Nigeria’s public health response to the Covid-19 pandemic
The novel coronavirus disease 2019, COVID-19, which is caused by severe acute respiratory syndrome \nvirus 2 (SARS-CoV-2) [1] was first reported in December 2019 by Chinese Health Authorities following an outbreak of pneumonia of unknown origin in Wuhan, Hubei Province [2,3]. SARS-CoV-2 is \nlikely of zoonotic origin, similar to SARS and Middle East Respiratory Syndrome (MERS), and transmitted between humans through respiratory droplets and fomit…
Environmental health (4 works) · Medicine (4 works) · Public health (4 works) · Virology (4 works) · Nursing (3 works) · Poliovirus (3 works) · Biostatistics (2 works) · Epidemiology (2 works) · Internal Medicine (2 works) · Pathology (2 works)